Approvals/TGA/TACROLIMUS XR SANDOZ tacrolimus (as monohydrate) 3 mg prolonged-release capsule blister pack

Approved

STANDARD

TACROLIMUS XR SANDOZ tacrolimus (as monohydrate) 3 mg prolonged-release capsule blister pack

Sandoz Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 014a956855f0c714
Product Name: TACROLIMUS XR SANDOZ tacrolimus (as monohydrate) 3 mg prolonged-release capsule blister pack
Artg Id: 366776
Artg Name: TACROLIMUS XR SANDOZ tacrolimus (as monohydrate) 3 mg prolonged-release capsule blister pack
Sponsor: Sandoz Pty Ltd
Company Detail Path: /organization/sandoz-pty-ltd
Artg Date: 2022-08-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/6c641f65b8f39f40fac2d02acf32494e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/695c33f2e19941ee5eb7e584ce349ebd.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

014a956855f0c714

Type

Standard